The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

AdChoices
 

LifePoint Health Inc

Nasdaq: LPNT
Last

(U.S.) $59.23

Today's change+1.03 +1.77%
Updated September 30 4:00 PM EDT. Delayed by at least 15 minutes.
 

LifePoint Health Inc

Nasdaq: LPNT
Last

(U.S.) $59.23

Today's change+1.03 +1.77%
Updated September 30 4:00 PM EDT. Delayed by at least 15 minutes.

LifePoint Health Inc crosses above 50-day moving average

LifePoint Health Inc closed up sharply Friday, rallying (U.S.)$1.03 or 1.77% to (U.S.)$59.23 and crossing above its 50-day moving average. Over the last five days, shares have gained 1.01%, but are down 19.31% for the last year to date. Shares have underperformed the S&P 500 by 29.39% during the last year.

Key company metrics

  • Open(U.S.) $58.47
  • Previous close(U.S.) $58.20
  • High(U.S.) $59.54
  • Low(U.S.) $57.45
  • Bid / Ask(U.S.) $57.02 / (U.S.) $70.08
  • YTD % change-19.31%
  • Volume342,844
  • Average volume (10-day)386,920
  • Average volume (1-month)417,664
  • Average volume (3-month)446,178
  • 52-week range(U.S.) $54.82 to (U.S.) $76.39
  • Beta0.88
  • Trailing P/E19.92×
  • P/E 1 year forward16.59×
  • Forward PEG2.41×
  • Indicated annual dividend--
  • Dividend yield0.00%
  • Trailing EPS(U.S.) $2.97
Updated September 30 4:00 PM EDT. Delayed by at least 15 minutes.

Profit

Net Profit (TTM)
+2.48%

Based on its net profit margin of 2.48%, LifePoint Health Inc is among the more effective companies in its industry at turning revenues into bottom line profit.
Company Books

S&P TSX0.19%Sector:HealthcareIndustry:Healthcare Facilities
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q2/2016Q1/2016Q4/2015Q3/2015
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedJun 30, 201606/30/2016Mar 31, 201603/31/2016Dec 31, 201512/31/2015Sep 30, 201509/30/2015
Revenue1,5921,5811,3711,310
Total other revenue--------
Total revenue1,5921,5811,3711,310
Gross profit563553500478
Total cost of revenue1,0291,028871832
Total operating expense1,5621,5441,2881,237
Selling / general / administrative346356286274
Research & development--------
Depreciation / amortization85867270
Interest expense (income), net operating--------
Unusual expense (income)22102
Other operating expenses, total41353031
Operating income30378372
Interest income (expense), net non-operating--------
Gain (loss) on sale of assets--------
Other--------
Income before tax30378772
Income after tax20245546
Income tax, total10133126
Net income17225344
Total adjustments to net income--------
Net income before extra. items17225344
Minority interest-3-2-2-2
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items17225344
Inc. avail. to common incl. extra. items17225344
Diluted net income17225344
Dilution adjustment--------
Diluted weighted average shares44454646
Diluted EPS excluding extraordinary itemsvalue per share0.380.491.160.94
Dividends per sharevalue per share0.000.00--0.00
Diluted normalized EPSvalue per share0.710.501.160.97